Edward J Kelly - Publications

Affiliations: 
University of Washington School of Pharmacy 
Area:
toxicology, drug metabolism, pharmacogenomics

81 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Jones-Isaac KA, Lidberg KA, Yeung CK, Yang J, Bain J, Ruiz M, Koenig G, Koenig P, Countryman S, Himmelfarb J, Kelly EJ. Development of a kidney microphysiological system hardware platform for microgravity studies. Npj Microgravity. 10: 54. PMID 38734683 DOI: 10.1038/s41526-024-00398-0  0.312
2023 Yeung C, Jones-Isaac K, Lindberg K, Yang J, Bain J, Ruiz M, Koenig G, Koenig P, Countryman S, Himmelfarb J, Kelly E. Development of a Kidney Microphysiological System Hardware Platform for Microgravity Studies. Research Square. PMID 38196654 DOI: 10.21203/rs.3.rs-3750478/v1  0.73
2023 Kelly E, Lindberg K, Jones-Isaac K, Yang J, Bain J, Wang L, MacDonald J, Bammler T, Calamia J, Thummel K, Yeung C, Countryman S, Koenig P, Himmelfarb J. Impact of microgravity on a three-dimensional microphysiologic culture of the human kidney proximal tubule epithelium: cell response to serum and vitamin D. Research Square. PMID 38196580 DOI: 10.21203/rs.3.rs-3778779/v1  0.74
2023 Hart A, Cesar F, Zelnick LR, O'Connor N, Bailey Z, Lo J, Van Ness K, Stanaway IB, Bammler TK, MacDonald JW, Thau MR, Himmelfarb J, Goss CH, Aitken M, Kelly EJ, et al. Identification of prognostic biomarkers for antibiotic associated nephrotoxicity in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 37949747 DOI: 10.1016/j.jcf.2023.10.021  0.421
2023 Chang SY, Huang W, Chapron A, Quiñones AJL, Wang J, Isoherranen N, Shen DD, Kelly EJ, Himmelfarb J, Yeung CK. Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney Disease. Pharmaceutical Research. PMID 37704895 DOI: 10.1007/s11095-023-03594-x  0.659
2022 Lidberg K, Himmelfarb J, Kelly E, Akilesh S. Authors' Reply: Serum Protein-induced Tubular Injury. Journal of the American Society of Nephrology : Jasn. 33: 1627-1628. PMID 35906085 DOI: 10.1681/ASN.2022060657  0.768
2022 Mahadeo A, Yeung CK, Himmelfarb J, Kelly EJ. Kidney microphysiological models for nephrotoxicity assessment. Current Opinion in Toxicology. 30. PMID 35495549 DOI: 10.1016/j.cotox.2022.03.002  0.669
2022 Lidberg K, Muthusamy S, Adil M, Mahadeo A, Yang J, Patel R, Wang L, Bammler T, Reichel J, Yeung C, Himmelfarb J, Kelly E, Akilesh S. Serum Protein Exposure Activates a Core Regulatory Program Driving Human Proximal Tubule Injury. Journal of the American Society of Nephrology : Jasn. PMID 35197326 DOI: 10.1681/ASN.2021060751  0.79
2021 Imaoka T, Huang W, Shum S, Hailey DW, Chang SY, Chapron A, Yeung CK, Himmelfarb J, Isoherranen N, Kelly EJ. Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system. Scientific Reports. 11: 21356. PMID 34725352 DOI: 10.1038/s41598-021-00338-y  0.642
2021 Arian CM, Imaoka T, Yang J, Kelly EJ, Thummel KE. Gutsy science: In vitro systems of the human intestine to model oral drug disposition. Pharmacology & Therapeutics. 107962. PMID 34478775 DOI: 10.1016/j.pharmthera.2021.107962  0.788
2021 Chen WY, Evangelista EA, Yang J, Kelly EJ, Yeung CK. Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing. Frontiers in Pharmacology. 12: 695920. PMID 34381363 DOI: 10.3389/fphar.2021.695920  0.817
2021 Van Ness KP, Cesar F, Yeung CK, Himmelfarb J, Kelly EJ. Microphysiological Systems in ADME Sciences. Clinical and Translational Science. PMID 34378335 DOI: 10.1111/cts.13132  0.624
2021 Lidberg KA, Annalora AJ, Jozic M, Elson DJ, Wang L, Bammler TK, Ramm S, Monteiro MB, Himmelfarb J, Marcus CB, Iversen PL, Kelly EJ. Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease. Scientific Reports. 11: 10711. PMID 34002000 DOI: 10.1038/s41598-021-90075-z  0.789
2021 Kowalski JP, Pelletier RD, McDonald MG, Kelly EJ, Rettie AE. Pharmacokinetics, metabolism and off-target effects in the rat of 8-[(1H- benzotriazol-1-yl)amino]octanoic acid, a selective inhibitor of human cytochrome P450 4Z1: -oxidation as a potential augmenting pathway for inhibition. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-56. PMID 33993844 DOI: 10.1080/00498254.2021.1930281  0.645
2021 Lidberg KA, Annalora AJ, Jozic M, Elson DJ, Wang L, Bammler TK, Ramm S, Monteiro MB, Himmelfarb J, Marcus CB, Iversen PL, Kelly EJ. Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease. Scientific Reports. 11: 4722. PMID 33633318 DOI: 10.1038/s41598-021-84194-w  0.811
2020 Nieskens TTG, Persson M, Kelly EJ, Sjögren AK. A multi compartment human kidney proximal tubule-on-a-chip replicates cell polarization-dependent cisplatin toxicity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 33020068 DOI: 10.1124/dmd.120.000098  0.335
2020 Basit A, Neradugomma NK, Wolford C, Fan PW, Murray B, Takahashi RH, Khojasteh SC, Smith BJ, Heyward S, Totah RA, Kelly EJ, Prasad B. CHARACTERIZATION OF DIFFERENTIAL TISSUE ABUNDANCE OF MAJOR NON-CYP ENZYMES IN HUMAN. Molecular Pharmaceutics. PMID 32955894 DOI: 10.1021/Acs.Molpharmaceut.0C00559  0.382
2020 Imaoka T, Yang J, Wang L, McDonald MG, Afsharinejad Z, Bammler TK, Van Ness K, Yeung CK, Rettie AE, Himmelfarb J, Kelly EJ. Microphysiological System Modeling of Ochratoxin A-Associated Nephrotoxicity. Toxicology. 152582. PMID 32905824 DOI: 10.1016/J.Tox.2020.152582  0.815
2020 Chapron A, Chapron BD, Hailey DW, Chang SY, Imaoka T, Thummel KE, Kelly E, Himmelfarb J, Shen D, Yeung CK. An Improved Vascularized, Dual-Channel Microphysiological System Facilitates Modeling of Proximal Tubular Solute Secretion. Acs Pharmacology & Translational Science. 3: 496-508. PMID 32566915 DOI: 10.1021/acsptsci.9b00078  0.664
2020 Zhang A, Li CY, Kelly EJ, Sheppard L, Cui JY. Transcriptomic profiling of PBDE-exposed HepaRG cells unveils critical lncRNA- PCG pairs involved in intermediary metabolism. Plos One. 15: e0224644. PMID 32101552 DOI: 10.1371/Journal.Pone.0224644  0.338
2020 Shum S, Imaoka T, Huang W, Chang S, Yeung C, Himmelfarb J, Kelly E, Isoherranen N. Predicting renal clearance of morphine and morphine‐6‐glucuronide using the “organ‐on‐a‐chip” technology and physiologically‐based pharmacokinetic modeling The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.04121  0.658
2020 Imaoka T, Shum S, Chang S, Chapron A, Yeung CK, Himmelfarb J, Isoherranen N, Kelly EJ. P7 - Utilization of a microphysiological system to model renal secretion of opioids in humans Drug Metabolism and Pharmacokinetics. 35. DOI: 10.1016/J.Dmpk.2020.04.008  0.675
2019 Sakolish C, Chen Z, Dalaijamts C, Mitra K, Liu Y, Fulton T, Wade TL, Kelly EJ, Rusyn I, Chiu WA. Predicting tubular reabsorption with a human kidney proximal tubule tissue-on-a-chip and physiologically-based modeling. Toxicology in Vitro : An International Journal Published in Association With Bibra. 104752. PMID 31857146 DOI: 10.1016/J.Tiv.2019.104752  0.407
2019 Yeung CK, Koenig P, Countryman S, Thummel KE, Himmelfarb J, Kelly EJ. Tissue Chips in Space-Challenges and Opportunities. Clinical and Translational Science. PMID 31524321 DOI: 10.1111/Cts.12689  0.599
2019 Sachar M, Kelly EJ, Unadkat JD. Mechanisms of CYP3A Induction During Pregnancy: Studies in HepaRG Cells. The Aaps Journal. 21: 45. PMID 30919109 DOI: 10.1208/S12248-019-0316-Z  0.327
2019 Maass C, Sorensen NB, Himmelfarb J, Kelly EJ, Stokes CL, Cirit M. Translational assessment of drug-induced proximal tubule injury using a kidney microphysiological system (MPS). Cpt: Pharmacometrics & Systems Pharmacology. PMID 30869201 DOI: 10.1002/psp4.12400  0.52
2018 Weber EJ, Lidberg KA, Wang L, Bammler TK, MacDonald JW, Li MJ, Redhair M, Atkins WM, Tran C, Hines KM, Herron J, Xu L, Monteiro MB, Ramm S, Vaidya V, ... ... Kelly EJ, et al. Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity. Jci Insight. 3. PMID 30568031 DOI: 10.1172/Jci.Insight.123673  0.8
2018 Rayner SG, Phong KT, Xue J, Lih D, Shankland SJ, Kelly EJ, Himmelfarb J, Zheng Y. Reconstructing the Human Renal Vascular-Tubular Unit In Vitro. Advanced Healthcare Materials. e1801120. PMID 30379416 DOI: 10.1002/Adhm.201801120  0.595
2018 Monteiro MB, Ramm S, Chandrasekaran V, Boswell SA, Weber EJ, Lidberg KA, Kelly EJ, Vaidya VS. A High-Throughput Screen Identifies DYRK1A inhibitor ID-8 that Stimulates Human Kidney Tubular Epithelial Cell Proliferation. Journal of the American Society of Nephrology : Jasn. PMID 30361326 DOI: 10.1681/Asn.2018040392  0.789
2018 Sakolish C, Weber EJ, Kelly EJ, Himmelfarb J, Mouneimne R, Grimm FA, House JS, Wade T, Han A, Chiu WA, Rusyn I. Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip. Scientific Reports. 8: 14882. PMID 30291268 DOI: 10.1038/S41598-018-33099-2  0.8
2018 Bajaj P, Chowdhury SK, Yucha R, Kelly EJ, Xiao G. Emerging Kidney Models to Investigate Metabolism, Transport and Toxicity of Drugs and Xenobiotics. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 30076203 DOI: 10.1124/Dmd.118.082958  0.447
2018 Chapron BD, Chapron A, Phillips B, Okoli MC, Shen DD, Kelly EJ, Himmelfarb J, Thummel KE. Reevaluating the role of megalin in renal vitamin D homeostasis using a human cell-derived microphysiological system. Altex. PMID 29999169 DOI: 10.14573/Altex.1803161  0.579
2017 Chang SY, Weber EJ, Sidorenko VS, Chapron A, Yeung CK, Gao C, Mao Q, Shen D, Wang J, Rosenquist TA, Dickman KG, Neumann T, Grollman AP, Kelly EJ, Himmelfarb J, et al. Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. Jci Insight. 2. PMID 29202460 DOI: 10.1172/Jci.Insight.95978  0.814
2017 Weber EJ, Himmelfarb J, Kelly EJ. Concise Review: Current and Emerging Biomarkers of Nephrotoxicity. Current Opinion in Toxicology. 4: 16-21. PMID 29057384 DOI: 10.1016/J.Cotox.2017.03.002  0.803
2017 Van Ness KP, Chang SY, Weber EJ, Zumpano D, Eaton DL, Kelly EJ. Microphysiological Systems to Assess Nonclinical Toxicity. Current Protocols in Toxicology. 73: 14.18.1-14.18.28. PMID 28777442 DOI: 10.1002/Cptx.27  0.821
2017 Lockhart CM, Smith TB, Yang P, Naidu M, Rettie AE, Nath A, Weleber R, Kelly EJ. Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in CYP4V2. The British Journal of Ophthalmology. PMID 28698241 DOI: 10.1136/Bjophthalmol-2016-309696  0.755
2017 Vernetti L, Gough A, Baetz N, Blutt S, Broughman JR, Brown JA, Foulke-Abel J, Hasan N, In J, Kelly E, Kovbasnjuk O, Repper J, Senutovitch N, Stabb J, Yeung C, et al. Corrigendum: Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle. Scientific Reports. 7: 44517. PMID 28300206 DOI: 10.1038/Srep44517  0.692
2017 Vernetti L, Gough A, Baetz N, Blutt S, Broughman JR, Brown JA, Foulke-Abel J, Hasan N, In J, Kelly E, Kovbasnjuk O, Repper J, Senutovitch N, Stabb J, Yeung C, et al. Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle. Scientific Reports. 7: 42296. PMID 28176881 DOI: 10.1038/srep42296  0.665
2017 Chang SY, Voellinger JL, Van Ness KP, Chapron B, Shaffer RM, Neumann T, White CC, Kavanagh TJ, Kelly EJ, Eaton DL. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity. Toxicology in Vitro : An International Journal Published in Association With Bibra. PMID 28089783 DOI: 10.1016/J.Tiv.2017.01.007  0.803
2016 Prasad B, Johnson K, Billington S, Lee CA, Chung GW, Brown CD, Kelly E, Himmelfarb J, Unadkat JD. Abundance of drug transporters in the human kidney cortex as quantified by LC-MS/MS proteomics. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 27621205 DOI: 10.1124/Dmd.116.072066  0.505
2016 Weber EJ, Chapron A, Chapron BD, Voellinger JL, Lidberg KA, Yeung CK, Wang Z, Yamaura Y, Hailey DW, Neumann T, Shen DD, Thummel KE, Muczynski KA, Himmelfarb J, Kelly EJ. Development of a microphysiological model of human kidney proximal tubule function. Kidney International. 90: 627-37. PMID 27521113 DOI: 10.1016/J.Kint.2016.06.011  0.792
2016 Parkinson OT, Teitelbaum AM, Whittington D, Kelly EJ, Rettie AE. Species Differences in Microsomal Oxidation and Glucuronidation of 4-Ipomeanol: Relationship to Target Organ Toxicity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 27468999 DOI: 10.1124/Dmd.116.070003  0.791
2016 Chang SY, Weber EJ, Van Ness KP, Eaton DL, Kelly EJ. Liver and Kidney on Chips: Microphysiological Models to Understand Transporter Function. Clinical Pharmacology and Therapeutics. PMID 27448090 DOI: 10.1002/Cpt.436  0.809
2016 Farooq M, Kelly EJ, Unadkat JD. CYP2D6 is inducible by endogenous and exogenous corticosteroids. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 26965986 DOI: 10.1124/Dmd.115.069229  0.361
2016 Voellinger JL, Kelly EJ. Pharmacogenetic profiling and metabolic activity of human embryonic stem cell derived hepatocytes: focus on CYP450-mediated oxidation Admet and Dmpk. 4: 62-83. DOI: 10.5599/Admet.4.2.280  0.8
2016 Kelly EJ, Voellinger JL. Stem Cells and Drug Metabolism Rsc Drug Discovery Series. 2016: 177-201. DOI: 10.1039/9781782622376-00177  0.767
2015 Adler M, Ramm S, Hafner M, Muhlich JL, Gottwald EM, Weber E, Jaklic A, Ajay AK, Svoboda D, Auerbach S, Kelly EJ, Himmelfarb J, Vaidya VS. A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro. Journal of the American Society of Nephrology : Jasn. PMID 26260164 DOI: 10.1681/Asn.2015010060  0.8
2015 Wiek C, Schmidt EM, Roellecke K, Freund M, Nakano M, Kelly EJ, Kaisers W, Yarov-Yarovoy V, Kramm CM, Rettie AE, Hanenberg H. Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol. The Biochemical Journal. 465: 103-14. PMID 25247810 DOI: 10.1042/Bj20140813  0.741
2014 Shuster DL, Risler LJ, Prasad B, Calamia JC, Voellinger JL, Kelly EJ, Unadkat JD, Hebert MF, Shen DD, Thummel KE, Mao Q. Identification of CYP3A7 for glyburide metabolism in human fetal livers. Biochemical Pharmacology. 92: 690-700. PMID 25450675 DOI: 10.1016/J.Bcp.2014.09.025  0.788
2014 Lockhart CM, Nakano M, Rettie AE, Kelly EJ. Generation and characterization of a murine model of Bietti crystalline dystrophy. Investigative Ophthalmology & Visual Science. 55: 5572-81. PMID 25118264 DOI: 10.1167/Iovs.13-13717  0.769
2014 Nakano M, Lockhart CM, Kelly EJ, Rettie AE. Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition. Drug Metabolism Reviews. 46: 247-60. PMID 24856391 DOI: 10.3109/03602532.2014.921190  0.79
2013 Kelly EJ, Wang Z, Voellinger JL, Yeung CK, Shen DD, Thummel KE, Zheng Y, Ligresti G, Eaton DL, Muczynski KA, Duffield JS, Neumann T, Tourovskaia A, Fauver M, Kramer G, et al. Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system. Stem Cell Research & Therapy. 4: S17. PMID 24564863 DOI: 10.1186/Scrt378  0.828
2013 Lee N, Hebert MF, Prasad B, Easterling TR, Kelly EJ, Unadkat JD, Wang J. Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancy. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 2225-32. PMID 24101703 DOI: 10.1124/Dmd.113.054072  0.314
2013 van der Wilden GM, Velmahos GC, Joseph DK, Jacobs L, Debusk MG, Adams CA, Gross R, Burkott B, Agarwal S, Maung AA, Johnson DC, Gates J, Kelly E, Michaud Y, Charash WE, et al. Successful nonoperative management of the most severe blunt renal injuries: a multicenter study of the research consortium of New England Centers for Trauma. Jama Surgery. 148: 924-31. PMID 23945834 DOI: 10.1001/Jamasurg.2013.2747  0.325
2013 Parkinson OT, Liggitt HD, Rettie AE, Kelly EJ. Generation and characterization of a Cyp4b1 null mouse and the role of CYP4B1 in the activation and toxicity of Ipomeanol. Toxicological Sciences : An Official Journal of the Society of Toxicology. 134: 243-50. PMID 23748241 DOI: 10.1093/Toxsci/Kft123  0.788
2012 Nakano M, Kelly EJ, Wiek C, Hanenberg H, Rettie AE. CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant. Molecular Pharmacology. 82: 679-86. PMID 22772592 DOI: 10.1124/Mol.112.080085  0.749
2012 Takakusa H, Mohar I, Kavanagh TJ, Kelly EJ, Kaspera R, Nelson SD. Protein tyrosine nitration of mitochondrial carbamoyl phosphate synthetase 1 and its functional consequences. Biochemical and Biophysical Research Communications. 420: 54-60. PMID 22402285 DOI: 10.1016/J.Bbrc.2012.02.114  0.306
2012 Parkinson OT, Kelly EJ, Bezabih E, Whittington D, Rettie AE. Bioactivation of 4-Ipomeanol by a CYP4B enzyme in bovine lung and inhibition by HET0016. Journal of Veterinary Pharmacology and Therapeutics. 35: 402-5. PMID 21919916 DOI: 10.1111/J.1365-2885.2011.01339.X  0.746
2012 Crouthamel MH, Kelly EJ, Ho RJ. Development and characterization of transgenic mouse models for conditional gene knockout in the blood-brain and blood-CSF barriers. Transgenic Research. 21: 113-30. PMID 21538071 DOI: 10.1007/S11248-011-9512-Z  0.757
2012 Kelly EJ, Yarov-Yarovoy V, Rettie AE. CYP4B1 (cytochrome P450, family 4, subfamily B, polypeptide 1) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/47413  0.622
2011 Kelly EJ, Nakano M, Rohatgi P, Yarov-Yarovoy V, Rettie AE. Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states. Molecular Interventions. 11: 124-32. PMID 21540472 DOI: 10.1124/Mi.11.2.10  0.773
2009 Nakano M, Kelly EJ, Rettie AE. Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 2119-22. PMID 19661213 DOI: 10.1124/Dmd.109.028530  0.72
2002 Kelly EJ, Erickson KE, Sengstag C, Eaton DL. Expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae reveals a functional role in aflatoxin B1 detoxification. Toxicological Sciences : An Official Journal of the Society of Toxicology. 65: 35-42. PMID 11752683 DOI: 10.1093/Toxsci/65.1.35  0.602
2001 Eaton DL, Bammler TK, Kelly EJ. Interindividual differences in response to chemoprotection against aflatoxin-induced hepatocarcinogenesis: Implications for human biotransformation enzyme polymorphisms Advances in Experimental Medicine and Biology. 500: 559-576. PMID 11764998 DOI: 10.1007/978-1-4615-0667-6_85  0.61
2001 Cheesman MJ, Kneller MB, Kelly EJ, Thompson SJ, Yeung CK, Eaton DL, Rettie AE. Purification and characterization of hexahistidine-tagged cyclohexanone monooxygenase expressed in Saccharomyces cerevisiae and Escherichia coli. Protein Expression and Purification. 21: 81-6. PMID 11162390 DOI: 10.1006/Prep.2000.1340  0.759
2000 Wang C, Bammler TK, Guo Y, Kelly EJ, Eaton DL. Mu-Class GSTs are responsible for aflatoxin B1-8,9-epoxide-conjugating activity in the nonhuman primate Macaca fascicularis liver Toxicological Sciences. 56: 26-36. PMID 10869451 DOI: 10.1093/Toxsci/56.1.26  0.556
1998 Tonge RP, Kelly EJ, Bruschi SA, Kalhorn T, Eaton DL, Nebert DW, Nelson SD. Role of CYP1A2 in the hepatotoxicity of acetaminophen: Investigations using Cyp1a2 null mice Toxicology and Applied Pharmacology. 153: 102-108. PMID 9875304 DOI: 10.1006/Taap.1998.8543  0.569
1998 Payne AS, Kelly EJ, Gitlin JD. Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation. Proceedings of the National Academy of Sciences of the United States of America. 95: 10854-9. PMID 9724794 DOI: 10.1073/Pnas.95.18.10854  0.3
1998 Quaife CJ, Kelly EJ, Masters BA, Brinster RL, Palmiter RD. Ectopic expression of metallothionein-III causes pancreatic acinar cell necrosis in transgenic mice. Toxicology and Applied Pharmacology. 148: 148-57. PMID 9465274 DOI: 10.1006/Taap.1997.8321  0.466
1997 Kelly EJ, Sandgren EP, Brinster RL, Palmiter RD. A pair of adjacent glucocorticoid response elements regulate expression of two mouse metallothionein genes. Proceedings of the National Academy of Sciences of the United States of America. 94: 10045-50. PMID 9294160 DOI: 10.1073/Pnas.94.19.10045  0.453
1996 Kelly EJ, Quaife CJ, Froelick GJ, Palmiter RD. Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. The Journal of Nutrition. 126: 1782-90. PMID 8683339 DOI: 10.1093/Jn/126.7.1782  0.464
1996 Kelly EJ, Palmiter RD. A murine model of Menkes disease reveals a physiological function of metallothionein. Nature Genetics. 13: 219-22. PMID 8640230 DOI: 10.1038/Ng0696-219  0.471
1995 Erickson JC, Masters BA, Kelly EJ, Brinster RL, Palmiter RD. Expression of human metallothionein-III in transgenic mice. Neurochemistry International. 27: 35-41. PMID 7655346 DOI: 10.1016/0197-0186(94)00166-R  0.465
1994 Masters BA, Kelly EJ, Quaife CJ, Brinster RL, Palmiter RD. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proceedings of the National Academy of Sciences of the United States of America. 91: 584-8. PMID 8290567 DOI: 10.1073/Pnas.91.2.584  0.479
1994 Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, Zambrowicz BP, Palmiter RD. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry. 33: 7250-9. PMID 8003488 DOI: 10.1021/Bi00189A029  0.467
1994 Masters B, Quaife C, Erickson J, Kelly E, Froelick G, Zambrowicz B, Brinster R, Palmiter R. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles The Journal of Neuroscience. 14: 5844-5857. DOI: 10.1523/Jneurosci.14-10-05844.1994  0.428
1992 Perez HD, Holmes R, Kelly E, McClary J, Andrews WH. Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils. Gene. 118: 303-304. PMID 1511907 DOI: 10.1016/0378-1119(92)90208-7  0.451
1992 Perez HD, Holmes R, Kelly E, Mcclary J, Chou Q, Andrews WH. Cloning of the gene coding for a human receptor for formyl peptides. Characterization of a promoter region and evidence for polymorphic expression. Biochemistry. 31: 11595-11599. PMID 1445895 DOI: 10.1021/Bi00161A044  0.465
1991 Perez HD, Kelly E, Elfman F, Armitage G, Winkler J. Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitis. Journal of Clinical Investigation. 87: 971-976. PMID 1999504 DOI: 10.1172/Jci115105  0.491
1990 Lobo E, Elfman F, Kelly E, Perez HD. Effect of phorbol myristate acetate on processing of formyl peptide receptors by human neutrophils. Biochimica Et Biophysica Acta. 1055: 193-196. PMID 2242385 DOI: 10.1016/0167-4889(90)90122-T  0.455
1988 Perez HD, Kelly E, Chenoweth D, Elfman F. Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin). Journal of Clinical Investigation. 82: 360-363. PMID 3392212 DOI: 10.1172/Jci113595  0.478
Show low-probability matches.